Deutsche Bank upgraded Novozymes to Buy from Hold with a price target of DKK 350, up from DKK 330. The analyst believes “now is the time to turn positive” on the shares given the strategic logic of the Chr Hansen deal. The firm expects the new company to generate peer-leading levels of organic growth and margins with best-in-class sustainability credentials.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVZMY:
